Cleared Traditional

K823583 - MYOTEST NERVE STIMULATOR

K823583 is an FDA 510(k) clearance for MYOTEST NERVE STIMULATOR, manufactured by Prothia USA, Inc.. The device is a Class 2 Anesthesiology device with product code BXN cleared through the Traditional 510(k) pathway after a 24-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Dec 1982
Decision
24d
Days
Class 2
Risk

K823583 is an FDA 510(k) clearance for the MYOTEST NERVE STIMULATOR. Classified as Stimulator, Nerve, Battery-powered (product code BXN), Class II - Special Controls.

Submitted by Prothia USA, Inc. (Walker, US). The FDA issued a Cleared decision on December 30, 1982 after a review of 24 days - a notably fast clearance cycle.

This device falls under the Anesthesiology FDA review panel, regulated under 21 CFR 868.2775 - the FDA anesthesiology and respiratory device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

FDA 510(k) Submission Details - K823583

510(k) Number K823583 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received December 06, 1982
Decision Date December 30, 1982
Days to Decision 24 days
Submission Type Traditional
Review Panel Anesthesiology (AN)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
116d faster than avg
Panel avg: 140d · This submission: 24d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

BXN Device Classification - Class 2, Special Controls

Product Code BXN Stimulator, Nerve, Battery-powered
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 868.2775
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Anesthesiology devices follow this clearance model.

Regulatory Peers - BXN Stimulator, Nerve, Battery-powered

All 62
Devices cleared under the same product code (BXN) and FDA review panel - the closest regulatory comparables to K823583.
PERIPHERAL NERVE STIMULATOR MODEL A400
K852962 · Fisher & Paykel Allied Products , Ltd. · Dec 1985
NERVE STIMULATOR Q10
K843175 · Acm Systems · Aug 1984
MYOGRAPH 2000
K830058 · Prothia USA, Inc. · Mar 1983
STIMPEN
K822139 · Neuro Technology · Sep 1982
DIGISTIM II
K822137 · Beuro Technology · Jul 1982
NEUROSTIM II
K822138 · Neuro Technology · Jul 1982